Suppr超能文献

阿托品对病态窦房结综合征患者窦房结及心房的电生理效应。

Electrophysiologic effects of atropine on sinus node and atrium in patients with sinus nodal dysfunction.

作者信息

Dhingra R C, Amat-Y-Leon F, Wyndham C, Denes P, Wu D, Miller R H, Rosen K M

出版信息

Am J Cardiol. 1976 Dec;38(7):848-55. doi: 10.1016/0002-9149(76)90797-9.

Abstract

Electrophysiologic studies were conducted in 21 patients with sinus nodal dysfunction before and after intravenous administration of 1 to 2 mg of atropine. The mean sinus cycle length (+/- standard error of the mean) was 1,171 +/- 35 msec before and 806 +/- 29 msec after administration of atropine (P less than 0.001). Mean sinus nodal recovery time determined at a aced rate of 130/min and maximal recovery time were, respectively, 1,426 +/- 75 and 1,690 +/- 100 msec before and 1,169 +/- 90 and 1,311 +/- 111 msec after atropine (P less than 0.001 and less than 0.001). Mean calculated sinoatrial conduction time, measured in 16 patients, was 113 +/- 8 msec before and 105 +/- 9.7 msec after atropine (difference not significant). Mean atrial effective refractory period, measured at an equivalent driven cycle length, was 262 +/- 11.1 msec before and 256 +/- 10.3 msec after atropine (not significant). Mean atrial functional refractory period was 302 +/- 12.5 msec before and 295 +/- 11.3 msec after atropine (not significant). The shortening of sinus cycle length and sinus recovery time with atropine was similar to that noted in patients without sinus nodal dysfunction. In contrast, atropine had insignificant effects on sinoatrial conduction and atrial refractoriness in this group whereas it shortens both in normal subjects. This finding may reflect altered perinodal and atrial electrophysiologic properties in patients with sinus node disease.

摘要

对21例窦房结功能障碍患者在静脉注射1至2毫克阿托品前后进行了电生理研究。注射阿托品前平均窦房结周期长度(±平均标准误差)为1171±35毫秒,注射后为806±29毫秒(P<0.001)。以130次/分钟的起搏频率测定的平均窦房结恢复时间和最大恢复时间,注射阿托品前分别为1426±75毫秒和1690±100毫秒,注射后分别为1169±90毫秒和1311±111毫秒(P<0.001和<0.001)。在16例患者中测量的平均计算窦房传导时间,注射阿托品前为113±8毫秒,注射后为105±9.7毫秒(差异无统计学意义)。在等效驱动周期长度下测量的平均心房有效不应期,注射阿托品前为262±11.1毫秒,注射后为256±10.3毫秒(无统计学意义)。平均心房功能不应期,注射阿托品前为302±12.5毫秒,注射后为295±11.3毫秒(无统计学意义)。阿托品使窦房结周期长度和窦房结恢复时间缩短的情况与无窦房结功能障碍的患者相似。相比之下,阿托品对该组患者的窦房传导和心房不应期影响不显著,而在正常受试者中它会使两者都缩短。这一发现可能反映了窦房结疾病患者窦房结周围和心房电生理特性的改变。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验